Publication | Open Access
Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion
253
Citations
37
References
2006
Year
CRS + IPHP presented acceptable morbidity, toxicity, and mortality rates, all of which support prospective Phase III clinical trials.
| Year | Citations | |
|---|---|---|
Page 1
Page 1